AstraZeneca Pharma India scores Crisil ESG rating of 57

AstraZeneca Pharma India scores Crisil ESG rating of 57. The company disclosed its ESG score, reflecting its environmental, social, and governance practices. A score of 57 indicates moderate sustainability performance compared to peers. This update is likely to interest long-term investors focused on responsible investing.

📊 STOCKS: $ASTRAZEN | 🏢 SECTOR: Pharma | #LOWIMPACT #ESG